Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Rolls-Royce Holdings (RR.) by Edward Sheldon in The Motley Fool
- Hold Legal & General Group (LGEN) by Harvey Jones in The Motley Fool
- Buy Abrdn (ABDN) by Andrew Mackie in The Motley Fool
- Buy ITV (ITV) by Christopher Ruane in The Motley Fool
- Sell BP (BP.) by Alan Oscroft in The Motley Fool
- Buy Persimmon (PSN) by James Beard in The Motley Fool
- Add Pershing Square Holdings Ltd NPV (PSH) by Ben McPoland in The Motley Fool
- Neutral Diploma (DPLM) by JP Morgan
- Buy Breedon Group (BREE) by Deutsche Bank
- Sell JD Sports Fashion (JD.) by Deutsche Bank
- Buy Grainger (GRI) by Deutsche Bank
- Buy Close Brothers Group (CBG) by Deutsche Bank
- Buy Spirent Communications (SPT) by Deutsche Bank
- Buy PZ Cussons (PZC) by Deutsche Bank
- Buy Norcros (NXR) by Deutsche Bank
- Avoid Thorpe (F.W.) (TFW) by Steve Moore in ShareProphets
- Strong Buy Eco buildings Group (ECOB) by Hot Stock Rockets in ShareProphets
- Buy Ariana Resources (AAU) by Hot Stock Rockets in ShareProphets
- Watch JD Sports Fashion (JD.) by Steve Moore in ShareProphets
- Avoid Speedy Hire (SDY) by Steve Moore in ShareProphets
Arecor Therapeutics (AREC) Share Price
Health Care Sector
NOTE: This is based on 2 open tips for Arecor Therapeutics (AREC)
| Latest Bid : 75.00p | Latest Ask : 78.00p |
| High Today : 76.50p | Low Today : 75.00p |
| This Years High : 199.00p | This Years Low : 66.00p |
| Volume : 221 | MKT Cap : £27.75M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Arecor Therapeutics (AREC) Overview
Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.Arecor Therapeutics (AREC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-07-19 16:30:00 19/07/2024 | 16.67% |
| Avoid | Steve Moore | Premium Only | 2024-06-10 14:15:00 10/06/2024 | 40.00% |
Arecor Therapeutics (AREC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 75.00p | Latest Ask : 78.00p |
| High Today : 76.50p | Low Today : 75.00p |
| This Years High : 199.00p | This Years Low : 66.00p |
| Volume : 221 | MKT Cap : £27.75M |
Arecor Therapeutics Overview
Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Arecor Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-07-19 16:30:00 19/07/2024 | 16.67% |
| Avoid | Steve Moore | Premium Only | 2024-06-10 14:15:00 10/06/2024 | 40.00% |